A detailed history of Gg Group Ventures, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Gg Group Ventures, LLC holds 427 shares of LLY stock, worth $321,706. This represents 0.49% of its overall portfolio holdings.

Number of Shares
427
Previous 343 24.49%
Holding current value
$321,706
Previous $311 Million 7.79%
% of portfolio
0.49%
Previous 0.43%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 15, 2024

BUY
$772.14 - $960.02 $64,859 - $80,641
84 Added 24.49%
427 $336 Million
Q2 2024

Aug 14, 2024

BUY
$724.87 - $909.04 $248,630 - $311,800
343 New
343 $311 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $716B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Gg Group Ventures, LLC Portfolio

Follow Gg Group Ventures, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gg Group Ventures, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gg Group Ventures, LLC with notifications on news.